Unicycive Therapeutics, Inc. (UNCY) Insider Trading Disclosures
Unicycive Therapeutics, Inc. (UNCY) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: UNCY
CIK: 1766140
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grassi & Co., CPAs, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerPatrick Fahey
Audit LocationJericho, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 3 | 2026-10-01 | 2026-10-01 | 3 Filing | 0001213900-26-105816 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-28 | CURRENT REPORT | 0001213900-26-104314 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-03 | CURRENT REPORT | 0001213900-26-104076 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097271 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001213900-26-090075 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | CURRENT REPORT | 0001213900-26-088061 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-088013 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003117 | View SEC Doc Filr Page |
| 4/A | 2026-07-28 | 2026-05-14 | 4/A Filing | 0001213900-26-082273 | View SEC Doc Filr Page |
| 4/A | 2026-07-28 | 2026-05-14 | 4/A Filing | 0001213900-26-082270 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-08 | — | SCHEDULE 13G/A Filing | 0001104659-26-081878 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-07-02 | CURRENT REPORT | 0001213900-26-074678 | View SEC Doc Filr Page |
| 144 | 2026-07-01 | — | 144 Filing | 0001178937-26-000032 | View SEC Doc Filr Page |
| DEFA14A | 2026-06-22 | — | CURRENT REPORT | 0001213900-26-070318 | View SEC Doc Filr Page |
| 8-K | 2026-06-22 | 2026-06-19 | CURRENT REPORT | 0001213900-26-070316 | View SEC Doc Filr Page |
| EFFECT | 2026-06-15 | — | EFFECT Filing | 9999999995-26-001996 | View SEC Doc Filr Page |
| 4/A | 2026-06-15 | 2026-05-14 | 4/A Filing | 0001213900-26-068922 | View SEC Doc Filr Page |
| 4/A | 2026-06-15 | 2026-05-14 | 4/A Filing | 0001213900-26-068921 | View SEC Doc Filr Page |
| 4/A | 2026-06-15 | 2026-05-14 | 4/A Filing | 0001213900-26-068920 | View SEC Doc Filr Page |
| 4/A | 2026-06-15 | 2026-05-14 | 4/A Filing | 0001213900-26-068919 | View SEC Doc Filr Page |
| 4/A | 2026-06-15 | 2026-05-14 | 4/A Filing | 0001213900-26-068917 | View SEC Doc Filr Page |
| 4/A | 2026-06-15 | 2026-05-14 | 4/A Filing | 0001213900-26-068915 | View SEC Doc Filr Page |
| CORRESP | 2026-06-11 | — | CORRESP Filing | 0001213900-26-067967 | View SEC Doc Filr Page |
| UPLOAD | 2026-06-11 | — | UPLOAD Filing | 0000000000-26-005886 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-05 | CURRENT REPORT | 0001213900-26-065828 | View SEC Doc Filr Page |